David Jensen

Writing from the perspective of more than three decades in the news business, Jensen brings a background in business and government to bear on the $3 billion California stem cell agency. Now retired, his career included a 10-year stint as executive business editor of The Sacramento Bee, legislative coverage for United Press International and two years as a press aide to Gov. Jerry Brown during his first term in office. Jensen has covered the stem cell agency since its inception from his sailboat/home located south of the border with visits to California from time to time.

Web Site: http://californiastemcellreport.blogspot.com/


Stem Cell Training Ending at California State Colleges?

Sep 24, 2014

CIRM video on the Bridges program

California’s $3 billion stem cell research effort is turning ever more strongly in the direction of pushing stem cell treatments into the clinic, raising concerns among some about at least one program that appears endangered.


It is the $17.5 million “Bridges” training project that involved 11 state and...

ViaCyte: Stem Cell Diabetes Therapy ‘Not Possible’ Without California Taxpayer Cash

Sep 12, 2014
ViaCyte: Stem Cell Diabetes Therapy ‘Not Possible’ Without California Taxpayer Cash

The California stem cell agency hit a couple of firsts this week when it pumped up its investment this week in the “teabag” diabetes therapy being developed by ViaCyte, Inc., of San Diego.

The effort, backed by $55 million from the agency, is the first clinical trial in the United States for a diabetes...

California Stem Cell Meeting Concludes; Links to Stories

Sep 10, 2014

BERKELEY, Ca. -- Directors of the California stem cell agency today concluded their meeting at 1:53 p.m. PDT. Look for more coverage of matters discussed at the meeting in the next week or so.

Here are links and excerpts from stories from today's session.

California Bets $55 Million on 'Teabag' Diabetes Treatment

BERKELEY, Ca. -- California...

Revolving Door Policy Tightened at California Stem Cell Agency

Sep 10, 2014

BERKELEY, Ca. -- Directors of the California stem cell agency today approved a measure aimed at easing conflicts of interest involving employees who may seek employment with recipients of the agency’s largess.


On a unanimous voice voice, the governing board  of the California Institute for Regenerative Medicine (CIRM) set a new revolving door...

CIRM Press Release on Viacyte Award on Diabetes

Sep 10, 2014

BERKELEY, Ca. -- The California stem cell has posted a press release on today's award to Viacyte, Inc., of San Diego, Ca., to speed up development of a human embryonic stem cell treatment for diabetes. Here is a link to the press release. 

California Bets $55 Million on ‘Teabag’ Diabetes Treatment

Sep 10, 2014
California Bets $55 Million on ‘Teabag’ Diabetes Treatment

BERKELEY, Ca. -- California today beefed up its investment in a “teabag” therapy for diabetes, bringing the total to $55 million in an effort to develop a “virtual cure” for an affliction that affects 347 million people worldwide.

It is believed to be the largest direct investment that the state has ever made in a...

California Stem Meeting Begins in Berkeley

Sep 10, 2014

BERKELEY, Ca. -- Directors of the $3 billion California stem cell agency opened their meeting this morning at 10:04 a.m. PDT with a "teabag" cure for  diabetes on their minds.Also on tap is consideration of a proposal to ease problems with conflic...

Coverage of California Stem Cell Meeting, Plus an Ohio Participation Possibility

Sep 9, 2014

The California Stem Cell Report will bring you on-the-scene, live, gavel-to-gavel coverage tomorrow of the meeting of the directors of the Golden State’s $3 billion stem cell research program.

Directors are expected to approve $16.6 million for a “teabag” treatment for diabetes that is being developed by Viacycte, Inc., of San Diego.  Also...

San Diego’s Viacyte Scoring Again with State Funding; Total Now Hits $55 Million

Sep 7, 2014

California’s stem cell research agency appears ready to pump another $16.6 million into a diabetes therapy effort that has already received $38.5 million from the Golden State.


At a total of more than $55 million, it is likely the single largest direct investment that the state of California has ever made in a business....

Tightening the Revolving Door at the California Stem Cell Agency

Sep 4, 2014
Tightening the Revolving Door at the California Stem Cell Agency

Directors of the California stem cell agency next week will consider a proposal aimed at partially addressing revolving-door and conflict-of-interest problems at the $3 billion research enterprise.


The proposal comes in the wake of a wave of unfavorable publicity this summer that embarrassed the agency when its former president, Alan Trounson, was named...

Stay connected to Sacramento Connect

Follow Sacramento Connect on Twitter  Find Sacramento Connect on Facebook  Sign up for the Sacramento Connect Newsletter

Advertisement

Categories

  • Hot Topics (2)
  • Shopping (802)
  • Top Stories (3423)

Advertisement